Detalles de la búsqueda
1.
Management of adult patients with CMML undergoing allo-HCT: recommendations from the EBMT PH&G Committee.
Blood
; 2024 Mar 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-38493484
2.
Cardiac effects of deferasirox in transfusion-dependent patients with myelodysplastic syndromes: TELESTO study.
Br J Haematol
; 204(5): 2049-2056, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38343073
3.
Inflammatory profile of lower risk myelodysplastic syndromes.
Br J Haematol
; 2024 May 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-38772913
4.
Genome-wide analysis toward the epigenetic aetiology of myelodysplastic syndrome disease progression and pharmacoepigenomic basis of hypomethylating agents drug treatment response.
Hum Genomics
; 17(1): 37, 2023 04 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-37098643
5.
Efficacy and safety of daratumumab with ixazomib and dexamethasone in lenalidomide-exposed patients after one prior line of therapy: Final results of the phase 2 study DARIA.
Am J Hematol
; 99(3): 396-407, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38298023
6.
Cause of death and excess mortality in patients with lower-risk myelodysplastic syndromes (MDS): A report from the European MDS registry.
Br J Haematol
; 200(4): 451-461, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36335984
7.
Health-related quality of life in patients with relapsed/refractory multiple myeloma treated with pomalidomide and dexamethasone ± subcutaneous daratumumab: Patient-reported outcomes from the APOLLO trial.
Am J Hematol
; 97(4): 481-490, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35089607
8.
Contingent Synergistic Interactions between Non-Coding RNAs and DNA-Modifying Enzymes in Myelodysplastic Syndromes.
Int J Mol Sci
; 23(24)2022 Dec 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-36555712
9.
Daratumumab plus pomalidomide and dexamethasone versus pomalidomide and dexamethasone alone in previously treated multiple myeloma (APOLLO): an open-label, randomised, phase 3 trial.
Lancet Oncol
; 22(6): 801-812, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-34087126
10.
The effect of 5-azacytidine treatment delays and dose reductions on the prognosis of patients with myelodysplastic syndrome: how to optimize treatment results and outcomes.
Br J Haematol
; 192(6): 978-987, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32862447
11.
Upregulated hypoxia inducible factor 1α signaling pathway in high risk myelodysplastic syndrome and acute myeloid leukemia patients is associated with better response to 5-azacytidine-data from the Hellenic myelodysplastic syndrome study group.
Hematol Oncol
; 39(2): 231-242, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-33332639
12.
A multicenter cross-sectional study of the quality of life and iron chelation treatment satisfaction of patients with transfusion-dependent ß-thalassemia, in routine care settings in Western Greece.
Qual Life Res
; 30(2): 467-477, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-32920766
13.
TACI Mutations in Primary Antibody Deficiencies: A Nationwide Study in Greece.
Medicina (Kaunas)
; 57(8)2021 Aug 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-34441032
14.
Development of a core outcome set for myelodysplastic syndromes - a Delphi study from the EUMDS Registry Group.
Br J Haematol
; 191(3): 405-417, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32410281
15.
Impact of treatment with iron chelation therapy in patients with lower-risk myelodysplastic syndromes participating in the European MDS registry.
Haematologica
; 105(3): 640-651, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31278207
16.
Impact of red blood cell transfusion dose density on progression-free survival in patients with lower-risk myelodysplastic syndromes.
Haematologica
; 105(3): 632-639, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31171638
17.
Estimated glomerular filtration rate independently predicts outcome of azacitidine therapy in higher-risk Myelodysplastic syndromes. Results from 536 patients of the Hellenic National Registry of Myelodysplastic and Hypoplastic syndromes.
Hematol Oncol
; 38(4): 541-553, 2020 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-32495951
18.
Effect of induction therapy with lenalidomide, doxorubicin and dexamethasone on bone remodeling and angiogenesis in newly diagnosed multiple myeloma.
Int J Cancer
; 145(2): 559-568, 2019 07 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-30650184
19.
Allogeneic hematopoietic stem cell transplantation for MDS and CMML: recommendations from an international expert panel.
Blood
; 129(13): 1753-1762, 2017 03 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-28096091
20.
Impact of ZBTB7A hypomethylation and expression patterns on treatment response to hydroxyurea.
Hum Genomics
; 12(1): 45, 2018 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30285874